Tapentadol for the Treatment of Moderate-to-Severe Acute Pain in Children Under the Age of Two Years

BACKGROUND: Pharmacokinetics (PK), efficacy, and safety of the opioid analgesic tapentadol in the treatment of moderate-to-severe acute pain have so far not been investigated in pediatric patients <2 years of age. PATIENTS AND METHODS: Two multicenter, open-label trials assessed the pharmacokinet...

Descripción completa

Detalles Bibliográficos
Autores principales: Eissa, Ayman, Tarau, Eva, Beuter, Christoph, Radic, Tatjana, Watson, Estelle, Sohns, Melanie, Lefeber, Claudia, Hammer, Gregory B
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7853441/
https://www.ncbi.nlm.nih.gov/pubmed/33542653
http://dx.doi.org/10.2147/JPR.S269530

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7853441/
https://www.ncbi.nlm.nih.gov/pubmed/33542653
http://dx.doi.org/10.2147/JPR.S269530

Ejemplares similares